"Spot Sign" Selection of Intracerebral Hemorrhage to Guide Hemostatic Therapy "SPOTLIGHT"

Active, not recruiting

Phase 2 Results N/A

Summary of Purpose

This clinical trial will enroll 110 patients from approximately 15 Canadian stroke centres. Patients coming to the emergency department with bleeding in the brain not due to trauma or other known causes who can be treated within 6 hours of onset will undergo CT angiography using standard CT scanners ("CAT scan"). Those with a "spot sign", a type of marker on the CT scan that shows the brain is still bleeding,...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 22 June 2016.

1 May 2011 20 May 2011 1 May 2017 1 May 2017 1 Jun 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

  • David J Gladstone, MD